As people age, their ability to digest proteins diminishes and their energy level, fitness, muscle retention and bone loss are negatively impacted. Additionally, their immune systems become less responsive and unnecessary illnesses result as well as a reduction in ability to respond to vaccines, such as the flu or pneumonia shot.
Research demonstrates that non-denatured proteins, as found in TruActive™ products, are more easily digested. Additionally, the presence of immune active proteins stimulates elderly immune systems and improves vaccine response. Tamarack Biotics is currently conducting the following clinical trial to further prove this point.
Immunosenescence describes the condition whereby elderly people’s immune systems become less active and able to respond to a vaccine or illness. This double-blind, placebo-controlled study of 50 subjects investigates TruActive™’s effect on Pertussis vaccine response. The study is being conducted in California with UC Davis support. The study started in August 2016 and is expected to complete in early 2017.